Why Azzalure Has Earned Its Place in UK Clinics
If you’ve been in aesthetics for any length of time, you’ll know that the toxin conversation never really goes away. Patients ask about it, colleagues debate which product they prefer, and there’s always someone in a training group asking whether they should switch. Azzalure sits right in the middle of that conversation, a product with a genuinely loyal following in the UK, and for good reason.
Azzalure is manufactured by the French company Ipsen and marketed in the UK by Galderma. It’s a botulinum toxin type A product licensed for the temporary improvement of moderate to severe glabellar lines and lateral canthal lines in adults under 65. That’s the official version. What practitioners actually say about it is a bit more specific: it spreads predictably, it tends to kick in fast, and in the right hands it gives a soft, natural-looking finish that patients come back for.
Understanding the product you’re working with, not just its brand name, but its behaviour, is what separates good injectors from great ones. So before we get into where and how to buy azzalure, let’s make sure the clinical foundation is solid.
The Speywood Unit Problem (And Why It Matters More Than People Admit)
This is probably the most common source of error when practitioners are new to Azzalure, or when they’re transitioning from another toxin. The units are not interchangeable. Azzalure uses Speywood units (s.U), which are specific to the abobotulinumtoxinA formulation. The Speywood units of Azzalure are specific to the preparation and are not interchangeable with other preparations of botulinum toxin.
The conversion ratio from Speywood to international units is 2.5 to 1. In clinical practice, it may be that a conversion ratio of 3 to 1 is required on occasions, however 2.5 to 1 is an easy and safe conversion that provides clinical equivalence.
Getting this wrong is not just a minor dosing inconvenience. Underdosing leads to unhappy patients who feel their results faded too quickly. Overdosing increases the risk of brow ptosis or unintended muscle spread. Neither outcome is good for retention or reputation.
The reconstitution side of things is also worth flagging here. The gold standard for a 125-unit vial of Azzalure is 0.63ml of 0.9% sodium chloride. Your solution should be clear and free of visible particles after gentle rotation; never shake the vial as this can denature the protein. Once reconstituted, chemical and physical in-use stability has been demonstrated for 24 hours between 2 and 8 degrees Celsius. Keep a strict time log on every vial you open. It protects your patients and it protects your practice.
Azzalure vs Botox: An Honest Clinical Comparison
The azzalure vs botox debate comes up constantly, and most of the time it gets oversimplified into “which is better.” The honest answer is that they are different products with different clinical characteristics, and the right choice depends on the treatment area, the patient’s anatomy, and your own technique.
Both Botox (onabotulinumtoxinA, Allergan/AbbVie) and Azzalure (abobotulinumtoxinA, Galderma) are licensed botulinum toxin type A products for upper face indications in the UK. Both are well-evidenced. Both carry excellent safety profiles in trained hands. But they are not interchangeable, and treating them as if they are is one of the most common sources of variable outcomes in clinical practice.
The key clinical difference comes down to diffusion. Azzalure has a broader diffusion radius than Botox. This is not a flaw; it is simply a characteristic that requires you to adjust your approach depending on the treatment area and the outcome you are aiming for.
In practice, this means Azzalure can be particularly effective across larger surface areas like the forehead, where a wider spread works in your favour. For more targeted, precise work around the periorbital area, some practitioners prefer a product with tighter diffusion. Neither approach is wrong. The skill is in matching the product to the job.
On onset, Azzalure has a solid reputation for speed. Clinical data indicates that 60% of patients observe visible softening of glabellar lines within the first 48 hours, significantly shorter than the 3 to 5 days typically required for Botox to take effect. For patients with an event coming up mid-week, that faster onset is genuinely useful and worth communicating during consultation.
How Long Does Azzalure Last?
One of the questions practitioners field regularly from patients is around longevity. So how long does azzalure last in practice?
You can usually see results from Azzalure in 2 to 3 days, and the full effect usually happens in 7 to 10 days. In terms of duration, most patients can expect results to last between 3 and 4 months, though individual variation is real. Muscle mass, metabolism, lifestyle factors, and injection technique all play a role.
Azzalure is an excellent choice for those who want a tried-and-tested treatment with minimal downtime, especially for classic areas like the forehead and crow’s feet.
What this means practically is that the majority of your patients will be booking a review or top-up somewhere in the 12 to 16 week window. Treatment interval with Azzalure should not be more frequent than every three months. Build that into your patient communication from the start so there are no surprises.
Azzalure Reviews: What Practitioners Are Actually Saying
Spend any time in the aesthetics community and you’ll hear consistent themes when the azzalure reviews conversation comes up. Practitioners who use it regularly tend to mention three things: the fast onset, the predictable diffusion once you understand the Speywood system, and patient satisfaction with the natural-looking result.
That last point, cost-effectiveness, is relevant both for clinic economics and for patient pricing. A product that delivers reliable results and has efficient reconstitution is good for your margins. When patients are happy with their results and understand the value of what they are receiving, pricing conversations become easier too.
Watch our Faces Pharmacy TikTok videos where we discuss Azzalure and Botox. Short, practitioner-focused, and straight to the point.
How to Buy Azzalure Online Legally in the UK
Faces offers toxins and diluents including Azzalure through a verified practitioner-focused store. You can browse the available range at Faces Shop. All purchases are intended for licensed professionals only and must be used in line with UK regulatory requirements. To purchase prescription-only medicines through Faces, you will need to register for a practitioner account, provide your professional credentials and relevant qualifications as part of the verification process, and connect with a prescriber within the Faces system. This prescriber connection is a requirement for accessing POMs through the platform, ensuring that every purchase sits within a compliant, legally sound supply chain. It is a straightforward process designed to keep you, your patients, and your practice protected.
FAQs
Can any practitioner buy Azzalure in the UK?
No. Only licensed medical professionals and verified aesthetic practitioners can buy Azzalure online in the UK. It is a prescription-only aesthetic product and cannot be sold to the general public. If you are a non-prescribing practitioner, you must work under a valid prescription from an authorised prescriber.
How many units of Azzalure do I need per area?
This depends on the treatment area and the patient. For glabellar lines, the recommended dose is 50 Speywood units divided into 5 injection sites, with 10 Speywood units administered intramuscularly at right angles to the skin. For lateral canthal lines, the recommended dose per side is 30 Speywood units divided into 3 injection sites, with 10 Speywood units administered intramuscularly into each injection point. Always refer to the current SmPC for licensed dosing guidance.
Is Azzalure suitable for all patients?
Not all patients are appropriate candidates. Azzalure is contraindicated in patients with hypersensitivity to the active substance, presence of infection at the proposed injection site, and conditions including myasthenia gravis, Eaton Lambert Syndrome, or amyotrophic lateral sclerosis. It is not indicated for patients under 18 or over 65, and pregnant and lactating women should not use this product as not enough clinical data has been collected to suggest that it is safe. A thorough consultation and medical history review is essential before every treatment.
What is the difference between Azzalure and Dysport?
Azzalure is the aesthetic version of Dysport for European Union member states. It is a local muscle relaxant adapted from the botulinum neuromodulator type-A of Dysport and is specifically designed for use in aesthetic indications. The active substance and formulation are the same. The difference is primarily one of branding and market, not clinical profile.
How should I handle treatment failures or reduced effect with Azzalure?
If a patient reports that their results are less effective than previous treatments, consider whether the dosing was appropriate, whether technique or injection placement needs reviewing, and whether there are any patient-side factors such as increased muscle mass or metabolic rate affecting longevity. Resistance through neutralising antibody formation is possible but rare when treatment intervals are observed correctly. Do not administer retreatment sooner than every three months, and consult the SmPC for guidance on managing repeat treatment scenarios.